{"id":12368,"date":"2023-03-09T10:19:27","date_gmt":"2023-03-09T10:19:27","guid":{"rendered":"https:\/\/sunpharma.com\/?page_id=12368"},"modified":"2026-06-02T14:48:38","modified_gmt":"2026-06-02T09:18:38","slug":"south-africa-pvg-medicine-safety-information","status":"publish","type":"page","link":"https:\/\/sunpharma.com\/he\/south-africa-pvg-medicine-safety-information\/","title":{"rendered":"South Africa PVG &#8211; Medicine Safety Information"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; custom_margin=&#8221;3px||||false|false&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; top_divider_color=&#8221;#f7941e&#8221; sticky_position=&#8221;top&#8221; sticky_offset_top=&#8221;3px&#8221; da_disable_devices=&#8221;off|off|off&#8221; saved_tabs=&#8221;all&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row use_custom_gutter=&#8221;on&#8221; gutter_width=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; z_index=&#8221;500&#8243; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;0px||0px||false|true&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_menu menu_id=&#8221;51&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; menu_font=&#8221;|600|||||||&#8221; menu_font_size=&#8221;18px&#8221; background_color=&#8221;#878786&#8243; z_index=&#8221;179&#8243; background_layout=&#8221;dark&#8221; custom_margin=&#8221;|0px|0px|0px|false|true&#8221; custom_padding=&#8221;10px||10px|110px|false|false&#8221; sticky_position=&#8221;top&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_menu][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; fullwidth=&#8221;on&#8221; _builder_version=&#8221;4.16&#8243; parallax=&#8221;on&#8221; animation_style=&#8221;fade&#8221; da_disable_devices=&#8221;off|off|off&#8221; saved_tabs=&#8221;all&#8221; collapsed=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_fullwidth_header title=&#8221;South Africa&#8221; header_fullscreen=&#8221;on&#8221; button_one_url=&#8221;#visionvalues&#8221; button_two_url=&#8221;#codeofconduct&#8221; _builder_version=&#8221;4.16&#8243; title_font=&#8221;|700|||||||&#8221; title_text_color=&#8221;#f7941e&#8221; title_font_size=&#8221;40px&#8221; title_line_height=&#8221;1.2em&#8221; content_font=&#8221;||||||||&#8221; content_text_color=&#8221;#000000&#8243; subhead_font=&#8221;||||||||&#8221; subhead_text_color=&#8221;rgba(0,0,0,0.6)&#8221; subhead_font_size=&#8221;22px&#8221; background_color=&#8221;rgba(255,255,255,0.7)&#8221; custom_button_one=&#8221;on&#8221; button_one_text_size=&#8221;20px&#8221; button_one_text_color=&#8221;#ffffff&#8221; button_one_bg_color=&#8221;#f7941e&#8221; button_one_border_width=&#8221;0px&#8221; button_one_font=&#8221;|||on|||||&#8221; button_one_use_icon=&#8221;off&#8221; custom_button_two=&#8221;on&#8221; button_two_text_size=&#8221;20px&#8221; button_two_text_color=&#8221;rgba(0,0,0,0.7)&#8221; button_two_bg_color=&#8221;#ffffff&#8221; button_two_border_width=&#8221;0px&#8221; button_two_font=&#8221;|||on|||||&#8221; button_two_use_icon=&#8221;off&#8221; button_two_custom_margin=&#8221;||||false|false&#8221; button_two_custom_margin_tablet=&#8221;&#8221; button_two_custom_margin_phone=&#8221;|||1px|false|false&#8221; button_two_custom_margin_last_edited=&#8221;on|desktop&#8221; button_two_custom_padding=&#8221;||||false|false&#8221; background_layout=&#8221;light&#8221; width=&#8221;50%&#8221; width_tablet=&#8221;&#8221; width_phone=&#8221;100%&#8221; width_last_edited=&#8221;on|phone&#8221; animation_style=&#8221;fade&#8221; animation_duration=&#8221;500ms&#8221; animation_delay=&#8221;300ms&#8221; title_font_tablet=&#8221;&#8221; title_font_phone=&#8221;&#8221; title_font_last_edited=&#8221;on|phone&#8221; content_font_tablet=&#8221;&#8221; content_font_phone=&#8221;&#8221; content_font_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||0px||true|false&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row use_custom_gutter=&#8221;on&#8221; gutter_width=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;0px||0px||true|true&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;60px|60px|60px|60px|true|true&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 style=\"font-weight: bold; font-size: 25px; color: #f7941e!important; line-height: 1.2em;\">Particulars<\/h2>\n<p>&nbsp;<\/p>\n<ul>\n<li><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2026\/05\/Recall-Letter_Ranceph-Susp-125-mg_5ml-_Final.pdf\"><span lang=\"EN-ZA\">RANCEPH SUSPENSION 125 MG\/5 ML \u2013 MEDICINE RECALL BATCH DFG4606A<\/span><\/a><\/li>\n<li><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2025\/04\/DHCPL-Topiramate_Risk-of-neurodevelopmental-disorders_Final.pdf\"><span lang=\"EN-ZA\">TOPIRAMATE \u2013 RISK OF NEURODEVELOPMENTAL DISORDERS<\/span><\/a><\/li>\n<li><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/08\/Important-safety-informationPSEUDOEPHEDRINE-CONTAINING-MEDICINES.pdf\"><span lang=\"EN-ZA\">PSEUDOEPHEDRINE-CONTAINING MEDICINES\u2013 RISK OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) AND REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME (RCVS)<\/span><\/a><\/li>\n<li><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/04\/Genotoxic-Anticancer-Medicines_DHCPL_Sun-Pharma-and-Other-Collaborators.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">RECOMMENDED CALCULATION OF CONTRACEPTION DURATION AFTER COMPLETION OF THERAPY TO MINIMISE THE RISK OF GENOTOXIC ANTICANCER MEDICINE-MEDIATED REPRODUCTIVE ADVERSE EVENTS<br \/>\n<\/a><\/li>\n<li><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/01\/DHPCL-VALACICLOVIR-_-ACICLOVIR-CONTAINING-MEDICINES-RISK-OF-DRUG-RE....pdf\" target=\"_blank\" rel=\"noopener noreferrer\">VALACICLOVIR\/ACICLOVIR &#8211; CONTAINING MEDICINES \u2013 RISK OF DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS)<br \/>\n<\/a><\/li>\n<li><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2023\/04\/GABAPENTINOIDS-RISK-OF-SERIOUS-BREATHING-DIFFICULTY.pdf\" target=\"_blank\" rel=\"noopener\">GABAPENTINOIDS \u2013 RISK OF SERIOUS BREATHING DIFFICULTY<\/a><\/li>\n<\/ul>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 style=\"font-weight: bold; font-size: 25px; color: #f7941e!important; line-height: 1.2em;\">aRMM-Topiramate <\/h2>\n<ul>\n<li>\n        <a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2026\/06\/Risk-awareness-form.pdf\"><span lang=\"EN-ZA\">RISK AWARENESS FORM<\/span><br \/>\n        <\/a>\n    <\/li>\n<li>\n        <a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2026\/06\/Topiramate-Patient-card.pdf\"><span lang=\"EN-ZA\">TOPIRAMATE &#8211; PATIENT CARD<\/span><br \/>\n        <\/a>\n    <\/li>\n<li>\n        <a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2026\/06\/Topiramate-PPP-HCP.pdf\"><span lang=\"EN-ZA\">TOPIRAMATE &#8211; PPP &#8211; HCP<\/span><br \/>\n        <\/a>\n    <\/li>\n<li>\n        <a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2026\/06\/Topiramate-PPP-Patient-guide.pdf\"><span lang=\"EN-ZA\">TOPIRAMATE &#8211; PPP &#8211; PATIENT GUIDE<\/span><br \/>\n        <\/a>\n    <\/li>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h2 style=\"font-weight: bold; font-size: 25px; color: #f7941e!important; line-height: 1.2em;\">DHCPL<\/h2>\n<ul>\n<li>\n        <a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2026\/06\/DHCPL_Levetiracetam-Risk-of-DRESS.pdf\"><span lang=\"EN-ZA\">LEVETIRACETAM \u2013 RISK OF DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS)<\/p>\n<p><\/span><br \/>\n        <\/a>\n    <\/li>\n<ul>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2022\/08\/SPIL-BRSR-Policy-2022.pdf\" target=\"_blank\" rel=\"noopener\"><\/a>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||0px||true|false&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row use_custom_gutter=&#8221;on&#8221; gutter_width=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;0px||0px||true|true&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_3_font_size=&#8221;30px&#8221; background_color=&#8221;rgba(242,159,78,0.06)&#8221; text_orientation=&#8221;center&#8221; custom_margin=&#8221;||||true|false&#8221; custom_padding=&#8221;30px|60px|30px|60px|true|true&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><a href=\"\/australian-privacy-policy\/\"><strong><span>Privacy Policy<\/span><\/strong><\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Particulars &nbsp; RANCEPH SUSPENSION 125 MG\/5 ML \u2013 MEDICINE RECALL BATCH DFG4606A TOPIRAMATE \u2013 RISK OF NEURODEVELOPMENTAL DISORDERS PSEUDOEPHEDRINE-CONTAINING MEDICINES\u2013 RISK OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) AND REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME (RCVS) RECOMMENDED CALCULATION OF CONTRACEPTION DURATION AFTER COMPLETION OF THERAPY TO MINIMISE THE RISK OF GENOTOXIC ANTICANCER MEDICINE-MEDIATED REPRODUCTIVE ADVERSE EVENTS VALACICLOVIR\/ACICLOVIR &#8211; [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"class_list":["post-12368","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>South Africa PVG - Medicine Safety Information - Sun Pharmaceutical Industries Ltd.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sunpharma.com\/he\/south-africa-pvg-medicine-safety-information\/\" \/>\n<meta property=\"og:locale\" content=\"he_IL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"South Africa PVG - Medicine Safety Information - Sun Pharmaceutical Industries Ltd.\" \/>\n<meta property=\"og:description\" content=\"Particulars &nbsp; RANCEPH SUSPENSION 125 MG\/5 ML \u2013 MEDICINE RECALL BATCH DFG4606A TOPIRAMATE \u2013 RISK OF NEURODEVELOPMENTAL DISORDERS PSEUDOEPHEDRINE-CONTAINING MEDICINES\u2013 RISK OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) AND REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME (RCVS) RECOMMENDED CALCULATION OF CONTRACEPTION DURATION AFTER COMPLETION OF THERAPY TO MINIMISE THE RISK OF GENOTOXIC ANTICANCER MEDICINE-MEDIATED REPRODUCTIVE ADVERSE EVENTS VALACICLOVIR\/ACICLOVIR - [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sunpharma.com\/he\/south-africa-pvg-medicine-safety-information\/\" \/>\n<meta property=\"og:site_name\" content=\"Sun Pharmaceutical Industries Ltd.\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-02T09:18:38+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u05d6\u05de\u05df \u05e7\u05e8\u05d9\u05d0\u05d4 \u05de\u05d5\u05e2\u05e8\u05da\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u05d3\u05e7\u05d41\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"South Africa PVG - Medicine Safety Information - Sun Pharmaceutical Industries Ltd.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sunpharma.com\/he\/south-africa-pvg-medicine-safety-information\/","og_locale":"he_IL","og_type":"article","og_title":"South Africa PVG - Medicine Safety Information - Sun Pharmaceutical Industries Ltd.","og_description":"Particulars &nbsp; RANCEPH SUSPENSION 125 MG\/5 ML \u2013 MEDICINE RECALL BATCH DFG4606A TOPIRAMATE \u2013 RISK OF NEURODEVELOPMENTAL DISORDERS PSEUDOEPHEDRINE-CONTAINING MEDICINES\u2013 RISK OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) AND REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME (RCVS) RECOMMENDED CALCULATION OF CONTRACEPTION DURATION AFTER COMPLETION OF THERAPY TO MINIMISE THE RISK OF GENOTOXIC ANTICANCER MEDICINE-MEDIATED REPRODUCTIVE ADVERSE EVENTS VALACICLOVIR\/ACICLOVIR - [&hellip;]","og_url":"https:\/\/sunpharma.com\/he\/south-africa-pvg-medicine-safety-information\/","og_site_name":"Sun Pharmaceutical Industries Ltd.","article_modified_time":"2026-06-02T09:18:38+00:00","twitter_card":"summary_large_image","twitter_misc":{"\u05d6\u05de\u05df \u05e7\u05e8\u05d9\u05d0\u05d4 \u05de\u05d5\u05e2\u05e8\u05da":"\u05d3\u05e7\u05d41"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/sunpharma.com\/south-africa-pvg-medicine-safety-information\/","url":"https:\/\/sunpharma.com\/south-africa-pvg-medicine-safety-information\/","name":"South Africa PVG - Medicine Safety Information - Sun Pharmaceutical Industries Ltd.","isPartOf":{"@id":"https:\/\/sunpharma.com\/#website"},"datePublished":"2023-03-09T10:19:27+00:00","dateModified":"2026-06-02T09:18:38+00:00","breadcrumb":{"@id":"https:\/\/sunpharma.com\/south-africa-pvg-medicine-safety-information\/#breadcrumb"},"inLanguage":"he-IL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sunpharma.com\/south-africa-pvg-medicine-safety-information\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/sunpharma.com\/south-africa-pvg-medicine-safety-information\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sunpharma.com\/"},{"@type":"ListItem","position":2,"name":"South Africa PVG &#8211; Medicine Safety Information"}]},{"@type":"WebSite","@id":"https:\/\/sunpharma.com\/#website","url":"https:\/\/sunpharma.com\/","name":"Sun Pharmaceutical Industries Ltd.","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sunpharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"he-IL"}]}},"_links":{"self":[{"href":"https:\/\/sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/12368","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sunpharma.com\/he\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sunpharma.com\/he\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sunpharma.com\/he\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/sunpharma.com\/he\/wp-json\/wp\/v2\/comments?post=12368"}],"version-history":[{"count":35,"href":"https:\/\/sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/12368\/revisions"}],"predecessor-version":[{"id":19377,"href":"https:\/\/sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/12368\/revisions\/19377"}],"wp:attachment":[{"href":"https:\/\/sunpharma.com\/he\/wp-json\/wp\/v2\/media?parent=12368"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}